Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C17H14O4 |
| Molecular Weight | 282.2907 |
| Optical Activity | ( + ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1CCC2=C1C=C(O)C(=C2)C(=O)C3=CC=CC=C3
InChI
InChIKey=XMTKXTUIUKKGIL-UHFFFAOYSA-N
InChI=1S/C17H14O4/c18-15-9-13-11(6-7-12(13)17(20)21)8-14(15)16(19)10-4-2-1-3-5-10/h1-5,8-9,12,18H,6-7H2,(H,20,21)
Oxindanac, a non-steroidal anti-inflammatory drug, and is a weak cyclooxygenase inhibitor possessed antipyretic activity. This drug is used as a veterinary inflammatory drug. In addition, oxindanac was studied in phase III clinical trials for the treatment of rheumatic disorders. However, this study was discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The anti-oedematous efficacy of oxindanac equals that of paracetamol in acute postoperative inflammation; are weak cyclooxygenase inhibitors more effective than strong inhibitors? | 1989 |
|
| The use of intradermal carrageenan in calves to estimate the dose of oxindanac, a nonsteroidal anti-inflammatory drug. | 1993 Oct |
|
| High performance liquid chromatography and pharmacokinetics of the non-steroidal anti-inflammatory drug oxindanac in calves. | 1994 Jun |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
99910-67-5
Created by
admin on Sat Dec 16 10:14:50 GMT 2023 , Edited by admin on Sat Dec 16 10:14:50 GMT 2023
|
PRIMARY | |||
|
68879
Created by
admin on Sat Dec 16 10:14:50 GMT 2023 , Edited by admin on Sat Dec 16 10:14:50 GMT 2023
|
PRIMARY | |||
|
PS75787KJI
Created by
admin on Sat Dec 16 10:14:50 GMT 2023 , Edited by admin on Sat Dec 16 10:14:50 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
